Candel Therapeutics (CADL) EBITDA Margin (2020 - 2023)
Candel Therapeutics' EBITDA Margin came in at -9145.10% for Q1 2023, up 19206.51 percentage points from -28351.61% a year earlier and up 16154.90 percentage points from the prior quarter.
Candel Therapeutics (CADL) EBITDA Margin (2020 - 2023) Analysis & Trends
Over the trailing twelve months to Mar 31, 2023, Candel Therapeutics reported EBITDA Margin of -17558.46%, up 6355.25 percentage points year-over-year; for FY2022, it came in at -26922.40%, down 6527.20 percentage points from FY2021.
- Going back by year, EBITDA Margin was -20395.20% in FY2021 (-9420.00 pp) and -10975.20% in FY2020.
- The Q1 2023 figure represents the highest quarterly EBITDA Margin since Q3 2020.
- Year-over-year, EBITDA Margin increased in 1 of the last seven quarters, with an average year-over-year change of -4146.53 percentage points.
- Business Quant data shows CADL's EBITDA Margin at -25300.00% (Q4 2022), -27693.55% (Q3 2022) and -27364.52% (Q2 2022) in the three quarters before Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Candel Therapeutics | 711.71 Mn | 108.61 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -9,145.10% |
| Dec 31, 2022 | -25,300.00% |
| Sep 30, 2022 | -27,693.55% |
| Jun 30, 2022 | -27,364.52% |
| Mar 31, 2022 | -28,351.61% |
| Dec 31, 2021 | -24,393.55% |
| Sep 30, 2021 | -25,832.26% |
| Jun 30, 2021 | -17,077.42% |
| Mar 31, 2021 | -14,938.71% |
| Dec 31, 2020 | -19,738.71% |
| Sep 30, 2020 | -8,722.58% |
Candel Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();